These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3102088

  • 1. Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma.
    Wiltshaw E, Westbury G, Harmer C, McKinna A, Fisher C.
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S10-2. PubMed ID: 3102088
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ifosfamide combination regimens for soft-tissue sarcoma.
    Stuart-Harris R, Dalley D, Bell DR, Levi J, Simes RJ, Wiltshaw E.
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S185-8. PubMed ID: 8453695
    [Abstract] [Full Text] [Related]

  • 4. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
    Coriat R, Mir O, Camps S, Ropert S, Billemont B, Leconte M, Larousserie F, Anract P, Alexandre J, Goldwasser F.
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):491-5. PubMed ID: 19588140
    [Abstract] [Full Text] [Related]

  • 5. High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
    Stuart-Harris RC, Harper PG, Parsons CA, Kaye SB, Mooney CA, Gowing NF, Wiltshaw E.
    Cancer Chemother Pharmacol; 1983 Feb; 11(2):69-72. PubMed ID: 6414732
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J, Kellner R, Seeber S.
    Cancer Chemother Pharmacol; 1993 Feb; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule.
    Serrone L, Zeuli M, Gamucci T, Nardi M, Cognetti F.
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):206-10. PubMed ID: 11320663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or adriamycin and ifosfamide.
    Weh HJ, Zügel M, Wingberg D, Schwarz R, Zornig C, Dietel M, Hossfeld DK.
    Onkologie; 1990 Dec; 13(6):448-52. PubMed ID: 2128712
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
    Bui BN, Chevallier B, Chevreau C, Krakowski I, Peny AM, Thyss A, Maugard-Louboutin C, Cupissol D, Fargeot P, Bonichon F.
    J Clin Oncol; 1995 Oct; 13(10):2629-36. PubMed ID: 7595717
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas.
    Skubitz KM, Hamdan H, Thompson RC.
    Cancer; 1993 Nov 15; 72(10):2963-9. PubMed ID: 8221562
    [Abstract] [Full Text] [Related]

  • 17. Combination of 5-fluorouracil, adriamycin, ifosfamide and cisplatin in metastatic adult soft tissue sarcoma: results of a phase II study.
    Jäger E, Klein O, Wächter B, Bernhard H, Dippold W, Meyer zum Büschenfelde KH, Knuth A.
    Oncology; 1996 Nov 15; 53(1):58-63. PubMed ID: 8570133
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
    Elias A, Ryan L, Sulkes A, Collins J, Aisner J, Antman KH.
    J Clin Oncol; 1989 Sep 15; 7(9):1208-16. PubMed ID: 2504890
    [Abstract] [Full Text] [Related]

  • 20. Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
    Falkson G, Chasen MR, Falkson HC.
    Invest New Drugs; 1990 May 15; 8(2):215-9. PubMed ID: 2166721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.